Therapeutic Group: Oncology Presentation Lenvacent 4: Each capsule contains Lenvatinib mesylate INN equivalent to Lenvatinib 4 mg. Lenvacent 10: Each capsule contains Lenvatinib mesylate INN equivalent to Lenvatinib 10mg. Description Lenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib […]